Chris LethebyGuest
Kensy CooperriderHost[upbeat music] Welcome to Many Minds, a podcast about our world's spectacular varieties of mind and what we can learn from them.
We feature conversations that shed light on the diverse ways of thinking, sensing, and being that are out there.
In the last decade or so, interest in psychedelic drugs has surged, and not just among Silicon Valley types and psychiatrists and neuroscientists.
It's also surged among a stereotypically sober crowd, academic philosophers.
With their varied and sometimes transformative effects, psychedelics raise ethical questions, epistemological questions, metaphysical questions, questions about the nature of experience and the nature of mind.
Chris is a philosopher of cognitive science at the University of Western Australia and the author of the 2021 book, Philosophy of Psychedelics.
Here, Chris and I talk about the so-called classic psychedelics, LSD, psilocybin, ayahuasca, and others, and how interest in them has gone through three distinct waves.
We discuss the effects that these substances seem to have, in particular, their capacity to treat certain psychiatric conditions and their tendency to induce mystic-like experiences.
We consider the idea that psychedelics might serve as agents of moral enhancement, and we dig into the psychological and neural mechanisms by which psychedelics seem to have their effects.
Along the way, Chris and I talk about ontological shock, comforting delusions, brain plasticity, unselfing, microdosing, placebo effects and adverse effects, physicalism and idealism, the REBUS model, environmental virtues, plant consciousness, meditation, and much more.
Maybe this is obvious, but this episode is not just for the seasoned psychonauts out there.
Whatever your personal experience with these substances, they offer a distinctive window into the mind, a new way of grappling with big questions.
Perhaps this much is also obvious, but we're not here to encourage or endorse the use of psychedelics.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.
[upbeat music] Welcome to Many Minds, a podcast about our world's spectacular varieties of mind and what we can learn from them.
We feature conversations that shed light on the diverse ways of thinking, sensing, and being that are out there.
In the last decade or so, interest in psychedelic drugs has surged, and not just among Silicon Valley types and psychiatrists and neuroscientists.
It's also surged among a stereotypically sober crowd, academic philosophers.
With their varied and sometimes transformative effects, psychedelics raise ethical questions, epistemological questions, metaphysical questions, questions about the nature of experience and the nature of mind.
Chris is a philosopher of cognitive science at the University of Western Australia and the author of the 2021 book, Philosophy of Psychedelics.
Here, Chris and I talk about the so-called classic psychedelics, LSD, psilocybin, ayahuasca, and others, and how interest in them has gone through three distinct waves.
We discuss the effects that these substances seem to have, in particular, their capacity to treat certain psychiatric conditions and their tendency to induce mystic-like experiences.
We consider the idea that psychedelics might serve as agents of moral enhancement, and we dig into the psychological and neural mechanisms by which psychedelics seem to have their effects.
Along the way, Chris and I talk about ontological shock, comforting delusions, brain plasticity, unselfing, microdosing, placebo effects and adverse effects, physicalism and idealism, the REBUS model, environmental virtues, plant consciousness, meditation, and much more.
Maybe this is obvious, but this episode is not just for the seasoned psychonauts out there.
Whatever your personal experience with these substances, they offer a distinctive window into the mind, a new way of grappling with big questions.
Perhaps this much is also obvious, but we're not here to encourage or endorse the use of psychedelics.